Literature DB >> 21181275

Association study of single nucleotide polymorphisms in pre-miRNA and rheumatoid arthritis in a Han Chinese population.

Bin Yang1, Jun Long Zhang, Yun Ying Shi, Dong Dong Li, Jie Chen, Zhuo Chun Huang, Bei Cai, Xing Bo Song, Li Xin Li, Bin Wu Ying, Lan Lan Wang.   

Abstract

The aim of this study was to perform an association study between two single nucleotide polymorphisms (SNPs) rs2910164 G>C and rs3746444 T>C in pre-miRNA (hsa-mir-146a and hsa-mir-499) and rheumatoid arthritis (RA) in the Han Chinese population. 208 Han Chinese patients with RA and 240 healthy controls were recruited in this study. The SNPs was genotyped by polymerase chain reaction-restriction fragment length polymorphism. Anti-cyclic citrullinated peptide (anti-CCP) antibody was measured by enzyme linked immunosorbent assay and rheumatoid factor (RF) was measured by rate nephelometry. The genotype frequencies between cases and controls were compared by χ(2) analysis. No significant association between the SNPs (rs2910164 and rs3746444) and RA was observed (P = 0.631 and 0.775, respectively), and the SNPs did not show any association with the RF-positive (P = 0.631 and 0.775, respectively). However, there was a significant difference on the level of anti-CCP antibody between different genotypes in rs3746444 (P = 0.007). The heterozygote CT had significantly higher level of anti-CCP antibody compared with homozygote CC and TT (P = 0.054 and 0.003, respectively). We first investigated the association between the SNPs (rs2910164 G>C and rs3746444 T>C) in the pre-miRNA (hsa-mir-146a and hsa-mir-499) and RA in a Han Chinese population. We did not find a significant association between the SNPs and the susceptibility to RA, while the SNP rs3746444 may affect anti-CCP antibody production.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21181275     DOI: 10.1007/s11033-010-0633-x

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  46 in total

1.  Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.

Authors:  P E Lipsky; D M van der Heijde; E W St Clair; D E Furst; F C Breedveld; J R Kalden; J S Smolen; M Weisman; P Emery; M Feldmann; G R Harriman; R N Maini
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

2.  The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.

Authors:  G A Schellekens; H Visser; B A de Jong; F H van den Hoogen; J M Hazes; F C Breedveld; W J van Venrooij
Journal:  Arthritis Rheum       Date:  2000-01

Review 3.  Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review.

Authors:  J Avouac; L Gossec; M Dougados
Journal:  Ann Rheum Dis       Date:  2006-04-10       Impact factor: 19.103

4.  Comparative analysis of the mouse and human peptidylarginine deiminase gene clusters reveals highly conserved non-coding segments and a new human gene, PADI6.

Authors:  Stéphane Chavanas; Marie-Claire Méchin; Hidenari Takahara; Akira Kawada; Rachida Nachat; Guy Serre; Michel Simon
Journal:  Gene       Date:  2004-04-14       Impact factor: 3.688

5.  Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis.

Authors:  Floris A van Gaalen; Jill van Aken; Tom W J Huizinga; Geziena M Th Schreuder; Ferdinand C Breedveld; Eric Zanelli; Walther J van Venrooij; Cornelis L Verweij; René E M Toes; René R P de Vries
Journal:  Arthritis Rheum       Date:  2004-07

6.  Association of STAT4 with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in the Japanese population.

Authors:  Shu Kobayashi; Katsunori Ikari; Hirotaka Kaneko; Yuta Kochi; Kazuhiko Yamamoto; Kenichi Shimane; Yusuke Nakamura; Yoshiaki Toyama; Takeshi Mochizuki; So Tsukahara; Yasushi Kawaguchi; Chihiro Terai; Masako Hara; Taisuke Tomatsu; Hisashi Yamanaka; Takahiko Horiuchi; Kayoko Tao; Koji Yasutomo; Daisuke Hamada; Natsuo Yasui; Hiroshi Inoue; Mitsuo Itakura; Hiroshi Okamoto; Naoyuki Kamatani; Shigeki Momohara
Journal:  Arthritis Rheum       Date:  2008-07

7.  Human polymorphism at microRNAs and microRNA target sites.

Authors:  Matthew A Saunders; Han Liang; Wen-Hsiung Li
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

Review 8.  Anti-citrulline antibodies in the diagnosis and prognosis of rheumatoid arthritis: evolving concepts.

Authors:  Amalia Raptopoulou; Prodromos Sidiropoulos; Maria Katsouraki; Dimitrios T Boumpas
Journal:  Crit Rev Clin Lab Sci       Date:  2007       Impact factor: 6.250

Review 9.  MicroRNAs.

Authors:  Muller Fabbri; Carlo M Croce; George A Calin
Journal:  Cancer J       Date:  2008 Jan-Feb       Impact factor: 3.360

Review 10.  Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subsets.

Authors:  Annette H M van der Helm-van Mil; Tom W J Huizinga
Journal:  Arthritis Res Ther       Date:  2008-03-31       Impact factor: 5.156

View more
  27 in total

Review 1.  Association of MicroRNA-146a with autoimmune diseases.

Authors:  Wang-Dong Xu; Man-Man Lu; Hai-Feng Pan; Dong-Qing Ye
Journal:  Inflammation       Date:  2012-08       Impact factor: 4.092

2.  Possible use of miRNAs-146a and -499 expression and their polymorphisms as diagnostic markers for rheumatoid arthritis.

Authors:  Ghada Ayeldeen; Yasser Nassar; Hanan Ahmed; Olfat Shaker; Tamer Gheita
Journal:  Mol Cell Biochem       Date:  2018-04-26       Impact factor: 3.396

Review 3.  The association between susceptibility to inflammatory arthritis and miR-146a, miR-499 and IRAK1 polymorphisms. A meta-analysis.

Authors:  G G Song; S-C Bae; Y H Seo; J-H Kim; S J Choi; J D Ji; Y H Lee
Journal:  Z Rheumatol       Date:  2015-09       Impact factor: 1.372

4.  Genetic association of miRNA-146a with systemic lupus erythematosus in Europeans through decreased expression of the gene.

Authors:  S E Löfgren; J Frostegård; L Truedsson; B A Pons-Estel; S D'Alfonso; T Witte; B R Lauwerys; E Endreffy; L Kovács; C Vasconcelos; B Martins da Silva; S V Kozyrev; M E Alarcón-Riquelme
Journal:  Genes Immun       Date:  2012-01-05       Impact factor: 2.676

5.  Association between IRAK1 rs3027898 and miRNA-499 rs3746444 polymorphisms and rheumatoid arthritis : A case control study and meta-analysis.

Authors:  X-K Yang; P Li; C Zhang; R-X Leng; S Li; J Liu; B-Z Li; H-F Pan; D-Q Ye
Journal:  Z Rheumatol       Date:  2017-09       Impact factor: 1.372

Review 6.  The miR-146a polymorphism and susceptibility to systemic lupus erythematosus and rheumatoid arthritis : a meta-analysis.

Authors:  Y H Lee; S-C Bae
Journal:  Z Rheumatol       Date:  2015-03       Impact factor: 1.372

7.  IRAK1 rs3027898 C/A polymorphism is associated with risk of rheumatoid arthritis.

Authors:  Hui Zhang; Jian Pu; Xinxiang Wang; Li Shen; Gongyin Zhao; Chao Zhuang; Ruiping Liu
Journal:  Rheumatol Int       Date:  2012-03-27       Impact factor: 2.631

8.  MicroRNA-499 rs3746444 polymorphism and autoimmune diseases risk: a meta-analysis.

Authors:  Lechun Lu; Ying Tu; Lingxin Liu; Jue Qi; Li He
Journal:  Mol Diagn Ther       Date:  2014-04       Impact factor: 4.074

9.  Pre-micro RNA-499 Gene Polymorphism rs3746444 T/C is Associated with Susceptibility to Rheumatoid Arthritis in Egyptian Population.

Authors:  Shaimaa A Fattah; Maivel H Ghattas; Samy M Saleh; Dina M Abo-Elmatty
Journal:  Indian J Clin Biochem       Date:  2017-04-18

10.  Hsa-miR-499 rs3746444 polymorphism contributes to cancer risk: a meta-analysis of 12 studies.

Authors:  Man-Tang Qiu; Jing-Wen Hu; Xiang-Xiang Ding; Xin Yang; Zhi Zhang; Rong Yin; Lin Xu
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.